Fracture prevention using selective estrogen receptor modulator in patients with osteoporosis who received radiation therapy for cervical cancer

Phase 2

Recruiting

• Conditions: cervical cancer; cervical cancer/ radiotherapy/ pelvic fracture

• Registration Number: JPRN-jRCT1061220067
• Lead Sponsor: agao Shoji

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-11-04
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 80

Inclusion Criteria

Patients who meet all of the following criteria will be considered.
Patients with histologically confirmed cervical cancer.
Patients who are scheduled to receive radical radiotherapy, including concomitant intracavitary irradiation, as initial treatment for cervical cancer.
Postmenopausal patients ,menstrual amenorrhea for at least twelve months prior to the start of radiotherapy.
Patients who have given written consent to participate in the study.

Exclusion Criteria

Patients who are expected to have difficulty completing the study or subsequent follow-up, or who are deemed unsuitable by their physicians.

Study & Design

• Study Type: Interventional
• Study Design: Not specified